About Careers Internship MedBlog Contact us

Once-a-week Insulin Injections for Diabetics on the Anvil

by VR Sreeraman on September 8, 2008 at 3:07 PM
Once-a-week Insulin Injections for Diabetics on the Anvil

A breakthrough at the Research Institute of Mount Sinai Hospital may soon get many diabetics rid of the misery of taking insulin injections twice a day, for the researchers there have developed a once-a-week jab for type 2 diabetes patients.

Project leader Dr. Daniel Drucker has revealed that the new treatment called Exenatideis once a week, long-acting medications that imitates the action of GLP-1 (glucagon-like peptide), a naturally occurring hormone that is produced in the gut after eating, reports the Lancet.


Presently, patients are required to take to injections of currently available version of the drug known as Exenatide (Byetta).

During the study involving 300 patients, the researchers compared the results for patients self-injecting Exenatide once weekly against results from the conventional 14 injections a week.

They found that 75 per cent of patients receiving the once-weekly Exenatide treatment had their diabetes under control.

They also experienced fewer side effects and had no increased risk of hypoglycemia (decrease in blood sugars).

Source: ANI
Font : A-A+



Recommended Readings

Latest Diabetes News

Time Your Physical Activity Well to Stay Out of Diabetes
Physical activity or exercise in the morning and afternoon reduces type 2 diabetes risk, whereas evening exercise has no such association.
Staying Late at Night? Late Morning Wake-up? Your Chance of Diabetes may be High
Late sleepers and late risers may both have a higher risk of developing diabetes.
New Hope for Type 1 Diabetes: Semaglutide Reduces Insulin Dependency
Semaglutide, the anti-diabetic drug operating by stimulating insulin secretion, might have the potential to supplant the need for mealtime insulin injections.
Bacteria Treatment Shows Potential Against Insulin Resistance & Diabetes
The gut bacteria known as Lachnospiraceae might have the ability to boost insulin sensitivity, potentially providing a protective barrier against diabetes.
New Recommendations for Lowering Cardiovascular Risk In Diabetic Patients
Type 2 diabetes-led cardiovascular risk needs mandatory interdisciplinary, patient-centered care to reduce morbidity and mortality.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Once-a-week Insulin Injections for Diabetics on the Anvil Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests